Clinical Value of Pharmacogenomic Testing in a Patient Receiving FOLFIRINOX for Pancreatic Adenocarcinoma

Pharmacogenomic testing may have clinical value in the treatment of patients with gastrointestinal malignancies such as colorectal and pancreatic cancer. These types of cancer are often treated with combination chemotherapy regimens. These regimens can lead to severe adverse effects in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Velez-Velez, Lisa M., Hughes, Caren L., Kasi, Pashtoon Murtaza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249237/
https://www.ncbi.nlm.nih.gov/pubmed/30498448
http://dx.doi.org/10.3389/fphar.2018.01309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249237/
https://www.ncbi.nlm.nih.gov/pubmed/30498448
http://dx.doi.org/10.3389/fphar.2018.01309

Ejemplares similares